| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 9 | +44.44% | -0.21% | +0.36% | -0.57% | -3.13% | — |
| 14d | 9 | +22.22% | +7.38% | +1.63% | +5.75% | -8.87% | — |
| 30d | 9 | +33.33% | -1.19% | +3.76% | -4.95% | -11.78% | — |
| 60d | 9 | +33.33% | -0.99% | +4.33% | -4.11% | -18.15% | — |
| 90d | 9 | +22.22% | -1.59% | +5.33% | -6.93% | -39.07% | — |
| 180d | 9(2 pending) | +28.57% | -27.36% | +7.42% | -34.78% | -65.23% | — |
| 1y | 9(2 pending) | +0.00% | -68.86% | +14.32% | -83.18% | -81.06% | — |
| 2y | 9(3 pending) | +0.00% | -98.57% | +18.24% | -116.80% | -110.92% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 5,000 | $11.79 | $59.0K | 9,005 | Jun 9, 2026 | Jun 9, 2026 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 5,000 | $12.62 | $63.1K | 20,001 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 15,000 | $14.89 | $223.3K | 15,001 | Mar 18, 2026 | Mar 18, 2026 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 134,504 | — | — | 134,504 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 134,503 | — | — | 134,503 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 4,000 | $21.55 | $86.2K | 4,005 | May 15, 2025 | May 15, 2025 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 123,958 | — | — | 123,958 | Feb 25, 2025 | Feb 27, 2025 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | SALE Chief Executive Officer | 5.18 | $3.38 | $18 | 5 | Feb 5, 2025 | Feb 27, 2025 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | SALE Chief Executive Officer | 1 | $0.15 | $0 | 0 | Feb 5, 2025 | Feb 27, 2025 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | SALE Chief Executive Officer | 0.22 | $3.30 | $1 | 1 | Feb 5, 2025 | Feb 27, 2025 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 1,309,911 | — | — | 1,309,911 | Feb 27, 2024 | Mar 6, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 235,320 | — | — | 235,320 | Feb 27, 2024 | Mar 6, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 1,903,680 | — | — | 1,903,680 | Feb 27, 2024 | Mar 6, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 235,320 | — | — | 235,320 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 1,903,680 | — | — | 1,903,680 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 1,309,911 | — | — | 1,309,911 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 700,000 | — | — | 700,000 | Feb 23, 2023 | Feb 24, 2023 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 20,000 | $1.71 | $34.2K | 24,235 | Jun 29, 2022 | Jul 1, 2022 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 100,000 | $0.25 | $24.5K | 112,177 | Mar 25, 2022 | Mar 25, 2022 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 5,000,000 | — | — | 5,000,000 | Feb 15, 2022 | Feb 17, 2022 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 12,000 | $0.61 | $7.3K | 12,177 | Sep 28, 2021 | Sep 28, 2021 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 16,733 | $1.32 | $22.1K | 135,000 | Mar 24, 2021 | Mar 25, 2021 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 3,000,000 | — | — | 3,000,000 | Feb 23, 2021 | Feb 25, 2021 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 35,000 | $0.68 | $23.8K | 118,267 | Dec 30, 2020 | Dec 30, 2020 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASE Chief Executive Officer | 60,000 | $0.91 | $54.6K | 83,267 | Aug 13, 2020 | Aug 17, 2020 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 2,000,000 | — | — | 2,000,000 | May 4, 2020 | May 6, 2020 ↗ | View → |
| TNXP TONIX PHARMACEUTICALS HOLDING CORP. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Feb 25, 2020 | Feb 27, 2020 ↗ | View → |